Literature DB >> 32889660

Design and Development of a Risk Classification Instrument for Virological Failure in HIV, Using Psychosocial Determinants of Health: Preliminary Evidence from a South American Country.

Angela J Pereira-Morales1,2, Diana Acero Torres3, Mary Moreno Zapata3, Pedro Moreno Sierra3, Jhon Astaiza Hurtado3.   

Abstract

Predictive approaches in HIV to estimate a patient's risk to present with relevant health outcomes, such as hospitalizations and AIDS-related death, long before they happen, could be highly useful. We aimed to develop a risk classification instrument for virological failure through a scoring system that identifies patients with a low, medium, and high risk after six months of ART treatment. A case-control design was implemented through 355 HIV-positive Colombian adults who were assessed using the designed instrument. The variables with independent predictive values were selected using logistic regression analysis, and the diagnostic performance of the prediction score was evaluated using the area under the curve. The prediction score included relevant psychosocial and biological risk factors, some of them modifiable variables like substance use and low health literacy. The area under the curve value for the total prediction score was 0.85 (CI 0.80-0.90). Therefore, this instrument could be a valuable tool to identify at-risk patients of virological failure. In low and middle-income countries, the associated risk factors of virological failure are little known. Assessing such risk would lead to make individualized decisions regarding the patient's management and minimize the chance of non-desirable outcomes.

Entities:  

Keywords:  HIV/AIDS; Prediction score; Risk management; South America; Virological failure

Year:  2021        PMID: 32889660     DOI: 10.1007/s10461-020-03025-7

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  42 in total

1.  Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children.

Authors:  Theodore D Ruel; Moses R Kamya; Pelin Li; William Pasutti; Edwin D Charlebois; Teri Liegler; Grant Dorsey; Philip J Rosenthal; Diane V Havlir; Joseph K Wong; Jane Achan
Journal:  J Acquir Immune Defic Syndr       Date:  2011-01-01       Impact factor: 3.731

2.  Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.

Authors:  Brian Wells Pence; William C Miller; Bradley N Gaynes; Joseph J Eron
Journal:  J Acquir Immune Defic Syndr       Date:  2007-02-01       Impact factor: 3.731

Review 3.  Non-communicable diseases and HIV care and treatment: models of integrated service delivery.

Authors:  Malia Duffy; Bisola Ojikutu; Soa Andrian; Elaine Sohng; Thomas Minior; Lisa R Hirschhorn
Journal:  Trop Med Int Health       Date:  2017-06-19       Impact factor: 2.622

Review 4.  HIV treatment adherence, drug resistance, virologic failure: evolving concepts.

Authors:  Jean B Nachega; Vincent C Marconi; Gert U van Zyl; Edward M Gardner; Wolfgang Preiser; Steven Y Hong; Edward J Mills; Robert Gross
Journal:  Infect Disord Drug Targets       Date:  2011-04

5.  European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults.

Authors:  N Clumeck; A Pozniak; F Raffi
Journal:  HIV Med       Date:  2008-02       Impact factor: 3.180

6.  The Impacts of Residential Location on the Risk of HIV Virologic Failure Among ART Users in Durban, South Africa.

Authors:  Yi-No Chen; Daniella Coker; Michael R Kramer; Brent A Johnson; Kristin M Wall; Claudia E Ordóñez; Darius McDaniel; Alex Edwards; Anna Q Hare; Henry Sunpath; Vincent C Marconi
Journal:  AIDS Behav       Date:  2019-09

7.  Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland.

Authors:  Kiran Jobanputra; Lucy Anne Parker; Charles Azih; Velephi Okello; Gugu Maphalala; Bernard Kershberger; Mohammed Khogali; Johnny Lujan; Annick Antierens; Roger Teck; Tom Ellman; Rose Kosgei; Tony Reid
Journal:  PLoS One       Date:  2015-02-19       Impact factor: 3.240

8.  Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.

Authors:  Laurence Ahoua; Gunar Guenther; Loretxu Pinoges; Paul Anguzu; Marie-Laure Chaix; Clotilde Le Tiec; Suna Balkan; David Olson; Charles Olaro; Mar Pujades-Rodríguez
Journal:  BMC Infect Dis       Date:  2009-06-03       Impact factor: 3.090

9.  Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.

Authors:  Leigh F Johnson; Joel Mossong; Rob E Dorrington; Michael Schomaker; Christopher J Hoffmann; Olivia Keiser; Matthew P Fox; Robin Wood; Hans Prozesky; Janet Giddy; Daniela Belen Garone; Morna Cornell; Matthias Egger; Andrew Boulle
Journal:  PLoS Med       Date:  2013-04-09       Impact factor: 11.069

10.  Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study.

Authors:  Wei Kan; Tao Teng; Shujia Liang; Yanling Ma; Heng Tang; Tuerdi Zuohela; Guoqing Sun; Cui He; Kristin M Wall; Vincent C Marconi; Lingjie Liao; Xuebing Leng; Pengtao Liu; Yuhua Ruan; Hui Xing; Yiming Shao
Journal:  BMJ Open       Date:  2017-09-07       Impact factor: 2.692

View more
  1 in total

Review 1.  HIV and Substance Use in Latin America: A Scoping Review.

Authors:  Hanalise V Huff; Paloma M Carcamo; Monica M Diaz; Jamie L Conklin; Justina Salvatierra; Rocio Aponte; Patricia J Garcia
Journal:  Int J Environ Res Public Health       Date:  2022-06-12       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.